COVID-19 Variant ‘Eris’ Still Dominates, But Hospitalizations Are Slowing


According to the Centre for Disease Control, COVID-19 variant EG.5 also known as Eris continues to cause infections in the United States, accounting for almost 30 percent of all cases of Covid. Although the Centre’s Data Tracker estimates that COVID-19-related hospital admissions decreased about 3 percent percent nationally compared with the week before September 23, … Read more

FDA Approves Updated COVID-19 Booster Shots: What You Need to Know

FDA Approves New COVID Booster Shots

The U.S. Food and Drug Administration (FDA) has given the green light to updated COVID-19 booster shots from Pfizer and Moderna, marking a significant development in the ongoing battle against the virus. These booster shots are designed to combat the XBB.1.5 Omicron subvariant, are fully approved for individuals aged 12 and older, and are authorized for emergency use in those aged 6 months through 11 years.